Insider Transactions Reported by 12 Insiders of AVADEL PHARMACEUTICALS PLC

Symbol
AVDL on Nasdaq
Location
Dublin 2

Insiders trading volume in the past year

AVADEL PHARMACEUTICALS PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric J. Ende Director $2,148,423 +$235,218 +12% 29 Jul 2025
Gregory J. Divis Chief Executive Officer, Director $1,752,881 05 Mar 2025
Peter J. Thornton Director $1,124,087 +$80,450 +7.7% 29 Jul 2025
Geoffrey Michael Glass Director $1,096,772 15 Sep 2025
Linda Palczuk Director $911,103 +$39,640 +4.5% 15 Sep 2025
Mark Anthony McCamish Director $869,774 29 Jul 2025
THOMAS S. MCHUGH Chief Financial Officer $795,971 05 Mar 2025
Naseem Amin Director $214,940 29 Jul 2025
Jerad G. Seurer Gen. Counsel & Corp. Secretary $186,268 05 Mar 2025
Richard J. Kim Chief Commercial Officer 20 Feb 2024
Susan Rodriguez Chief Operating Officer 13 May 2025
Douglas J. Williamson Chief Medical Officer 14 Feb 2022

Recent Insider Transactions by Companies or Individuals for AVADEL PHARMACEUTICALS PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.